Inogen (INGN) Income towards Parent Company (2013 - 2026)
Inogen's (INGN) quarterly Income towards Parent Company came in at -$8.3 million in Q1 2026, down 34.82% year-on-year from -$12.8 million in Q1 2025, and down 193.39% on a QoQ basis from $8.9 million in Q4 2025.
Inogen (INGN) Income towards Parent Company (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Income towards Parent Company data on file, last reported at -$8.3 million in Q1 2026.
- On a quarterly basis, Income towards Parent Company fell 34.82% year-over-year to -$8.3 million in Q1 2026; TTM through Mar 2026 was -$8.9 million, a 58.14% increase from a year earlier, with the FY2025 full-year figure at -$6.7 million, up 77.31% from the prior year.
- Income towards Parent Company for Q1 2026 stood at -$8.3 million, down from $8.9 million in the prior quarter.
- Over the last five years, Income towards Parent Company for INGN reached as high as $72.5 million in Q4 2023 and fell as low as -$56.6 million in Q4 2022.
- Historically, Income towards Parent Company has averaged -$7.8 million across 5 years, with a median of -$6.2 million in 2025.
- Across the five-year window, Income towards Parent Company slumped 1841.8% in 2022 and soared 359.55% in 2025, its largest moves.
- Year by year, Income towards Parent Company stood at -$56.6 million in 2022, then jumped by 228.0% to $72.5 million in 2023, then tumbled by 104.74% to -$3.4 million in 2024, then surged by 359.55% to $8.9 million in 2025, then plunged by 193.39% to -$8.3 million in 2026.
- Per Business Quant data, the three most recent Income towards Parent Company figures were -$8.3 million in Q1 2026, $8.9 million in Q4 2025, and -$5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Inogen | 173.63 Mn | 63.46 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.32 Mn |
| Dec 31, 2025 | 8.91 Mn |
| Sep 30, 2025 | -5.29 Mn |
| Jun 30, 2025 | -4.15 Mn |
| Mar 31, 2025 | -6.17 Mn |
| Dec 31, 2024 | -3.43 Mn |
| Sep 30, 2024 | -5.96 Mn |
| Jun 30, 2024 | -5.59 Mn |
| Mar 31, 2024 | -14.58 Mn |
| Dec 31, 2023 | 72.46 Mn |
| Sep 30, 2023 | -45.72 Mn |
| Jun 30, 2023 | -9.83 Mn |
| Mar 31, 2023 | -20.35 Mn |
| Dec 31, 2022 | -56.61 Mn |
| Sep 30, 2022 | -9.51 Mn |
| Jun 30, 2022 | -3.44 Mn |
| Mar 31, 2022 | -14.21 Mn |
| Dec 31, 2021 | -22.88 Mn |
| Sep 30, 2021 | 12.17 Mn |
| Jun 30, 2021 | 5.10 Mn |